Allergic Rhinitis
Conditions
Interventions
Sheti Zhiqiu group:Sheti Zhiqiu formula
loratadine group:loratadine tablets
Combined group:Sheti Zhiqiu formula and loratadine tablets
Sponsors
Hospital of Chengdu university of TCM
Eligibility
Sex/Gender
All
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Meeting the diagnostic criteria of Western medicine and the syndrome differentiation standards of Traditional Chinese Medicine (TCM); 2. Aged =60 years with no restriction on gender; 3. No history of major illnesses or mental disorders; 4. Capable of independently completing the study questionnaire willing to participate in the study and signing the informed consent form.
Exclusion criteria
Exclusion criteria: Patients who used medications for atopic diseases such as antihistamines or antirhinitis drugs within 2 weeks prior to the study; 1. Patients with combined dysfunction of major organs; 2. Patients with comorbid bronchial asthma or other atopic diseases; 3. Patients with comorbid sinusitis nasal polyps or other nasal diseases or those who have undergone nasal surgery; 4. Patients with vitamin D toxicity hypercalcemia hyperphosphatemia accompanied by nephrogenic rickets; 5. Patients with other severe infections.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total IgE;25(OH)D2;25(OH)D3;Main related Symptoms;Serum Specific IgE;Secondary Symptoms;VDR; | — |
Secondary
| Measure | Time frame |
|---|---|
| IL-2;IL-10;serum total macrophage;IL-17;IFN-r;IL-4;Nasal signs; | — |
Countries
China
Contacts
Public ContactShunlin Peng
Hospital of Chengdu university of TCM
Outcome results
None listed